Abstract
People with treatment-resistant depression who have low-grade peripheral inflammation may benefit from add-on minocycline therapy, a small study has suggested (28 January 2021)[1]. Researchers from King’s College London examined the antidepressant effect of the antibiotic minocycline in a four-week, randomised controlled trial involving 39 patients with major depressive disorder. The investigators found no clear […]
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
